Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
AVGO

Broadcom

$241.19

0.64 (0.27%)

, CZR

Caesars

$12.53

0.025 (0.20%)

10:43
05/24/18
05/24
10:43
05/24/18
10:43
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

AVGO

Broadcom

$241.19

0.64 (0.27%)

CZR

Caesars

$12.53

0.025 (0.20%)

ELF

e.l.f. Beauty

$19.66

-0.13 (-0.66%)

QURE

uniQure

$33.50

0.63 (1.92%)

MRNS

Marinus Pharmaceuticals

$5.95

0.72 (13.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jun

  • 12

    Jun

ALBO

Albireo Pharma

$33.05

0.1 (0.30%)

, APTO

Aptose Biosciences

$3.44

0.03 (0.88%)

08:30
05/24/18
05/24
08:30
05/24/18
08:30
Options
Nine new option listings and one option delisting on May 24th »

New option listings for…

ALBO

Albireo Pharma

$33.05

0.1 (0.30%)

APTO

Aptose Biosciences

$3.44

0.03 (0.88%)

APY

Apergy

$44.55

-0.185 (-0.41%)

CERC

Cerecor

$3.83

-0.04 (-1.03%)

CLBS

Caladrius

$4.02

-0.08 (-1.95%)

HEAR

Turtle Beach

$17.33

1.93 (12.53%)

JEF

Jefferies Financial Group

$23.47

-0.045 (-0.19%)

SMMT

Summit Therapeutics

$13.45

-0.03 (-0.22%)

XENE

Xenon Pharmaceuticals

$5.60

0.05 (0.90%)

LUK

Leucadia

$23.47

-0.045 (-0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 12

    Jun

  • 13

    Jun

  • 04

    Oct

QURE

uniQure

$32.87

0.56 (1.73%)

07:44
05/24/18
05/24
07:44
05/24/18
07:44
Initiation
uniQure initiated at SunTrust »

uniQure initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRUS

Merus

$19.08

0.76 (4.15%)

07:25
05/24/18
05/24
07:25
05/24/18
07:25
Hot Stocks
Merus doses first patient in Phase 1 trial of MCLA-158 in colorectal cancer »

Merus has dosed the first…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QURE

uniQure

$32.87

0.56 (1.73%)

06:06
05/24/18
05/24
06:06
05/24/18
06:06
Initiation
uniQure initiated at SunTrust »

uniQure initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$98.12

-0.85 (-0.86%)

, SNY

Sanofi

$38.60

-0.33 (-0.85%)

04:55
05/24/18
05/24
04:55
05/24/18
04:55
Conference/Events
World Federation of Hemophilia to hold a conference »

2018 World Congress of…

ALNY

Alnylam

$98.12

-0.85 (-0.86%)

SNY

Sanofi

$38.60

-0.33 (-0.85%)

BMRN

BioMarin

$88.50

0.84 (0.96%)

BAYRY

Bayer

$0.00

(0.00%)

NVO

Novo Nordisk

$48.26

-0.37 (-0.76%)

PFE

Pfizer

$35.96

0.22 (0.62%)

SHPG

Shire

$166.38

-3.6 (-2.12%)

ONCE

Spark Therapeutics

$78.26

3.51 (4.70%)

QURE

uniQure

$32.87

0.56 (1.73%)

DNA

Bought by RHHBY

$0.00

(0.00%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 30

    May

  • 02

    Jun

  • 05

    Jun

  • 11

    Aug

  • 10

    Sep

  • 12

    Sep

  • 20

    Oct

  • 21

    Dec

  • 28

    Jan

  • 22

    Mar

Wednesday
ALNY

Alnylam

$98.97

-1.91 (-1.89%)

, SNY

Sanofi

$38.93

0.15 (0.39%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
World Federation of Hemophilia to hold a conference »

2018 World Congress of…

ALNY

Alnylam

$98.97

-1.91 (-1.89%)

SNY

Sanofi

$38.93

0.15 (0.39%)

BMRN

BioMarin

$87.66

-1.69 (-1.89%)

BAYRY

Bayer

$0.00

(0.00%)

NVO

Novo Nordisk

$48.63

-0.07 (-0.14%)

PFE

Pfizer

$35.74

-0.05 (-0.14%)

SHPG

Shire

$169.98

0.98 (0.58%)

ONCE

Spark Therapeutics

$74.75

1.72 (2.36%)

QURE

uniQure

$32.31

0.87 (2.77%)

DNA

Bought by RHHBY

$0.00

(0.00%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 30

    May

  • 05

    Jun

  • 11

    Aug

  • 10

    Sep

  • 12

    Sep

  • 20

    Oct

  • 21

    Dec

  • 28

    Jan

Tuesday
BMRN

BioMarin

$86.62

-2.73 (-3.06%)

, ONCE

Spark Therapeutics

$73.01

-0.02 (-0.03%)

12:52
05/22/18
05/22
12:52
05/22/18
12:52
Hot Stocks
FDA Commissioner says agency working to expedite gene therapy programs »

Scott Gottlieb, the…

BMRN

BioMarin

$86.62

-2.73 (-3.06%)

ONCE

Spark Therapeutics

$73.01

-0.02 (-0.03%)

AVXS

AveXis

$0.00

(0.00%)

RGNX

Regenxbio

$46.90

0.4 (0.86%)

BLUE

Bluebird Bio

$184.70

3.4 (1.88%)

ABEO

Abeona Therapeutics

$16.20

0.15 (0.93%)

NITE

Nightstar Therapeutics

$13.74

(0.00%)

VYGR

Voyager Therapeutics

$18.22

-0.36 (-1.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

  • 25

    May

  • 10

    Sep

  • 12

    Sep

ONCE

Spark Therapeutics

$74.00

0.97 (1.33%)

, BMRN

BioMarin

$85.77

-3.58 (-4.01%)

11:21
05/22/18
05/22
11:21
05/22/18
11:21
Recommendations
Spark Therapeutics, BioMarin analyst commentary at Citi »

Spark Therapeutics should…

ONCE

Spark Therapeutics

$74.00

0.97 (1.33%)

BMRN

BioMarin

$85.77

-3.58 (-4.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 25

    May

  • 10

    Sep

  • 12

    Sep

BMRN

BioMarin

$86.01

-3.34 (-3.74%)

, ONCE

Spark Therapeutics

$75.45

2.42 (3.31%)

09:52
05/22/18
05/22
09:52
05/22/18
09:52
Recommendations
BioMarin, Spark Therapeutics analyst commentary at Citi »

BioMarin shares…

BMRN

BioMarin

$86.01

-3.34 (-3.74%)

ONCE

Spark Therapeutics

$75.45

2.42 (3.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 25

    May

  • 10

    Sep

  • 12

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.